Company news

NATCO Pharma Limited news in 2021

NATCO Pharma Limited's news releases, calls and decks from 2021, newest first.

View company

NATCO Pharma receives approval for Molnupiravir Capsules 200 mg for the treatment of Covid-19 in India

December 29, 2021

Press Release Dec 28 2021

December 28, 2021

Press Release Nov 18 2021

November 18, 2021

Natco Pharma launches Everolimus tablets 10 mg in US market

October 4, 2021

Press Release Oct 01 2021

October 1, 2021

Press Release Sep 02 2021

September 2, 2021

Press Release Aug 20 2021

August 20, 2021

Press Release Aug 03 2021

August 3, 2021

Press Release Jul 07 2021

July 7, 2021

Press Release Jun 14 2021

June 14, 2021

Press Release May 22 2021

May 22, 2021

Press Release May 21 2021

May 21, 2021

Press Release May 17 2021

May 17, 2021

Press Release May 03 2021

May 3, 2021

Press Release Apr 26 2021

April 26, 2021

NATCO Pharma receives tentative approval for Ibrutinib tablets (generic for IMBRUVICA) ANDA in the US market

April 13, 2021

Press Release Apr 10 2021

April 10, 2021

NATCO Pharma forays into Pheromone based technology for Integrated Pest Management

March 16, 2021

Press Release Mar 15 2021

March 15, 2021

Press Release Mar 08 2021

March 8, 2021

NATCO Pharma launches Brivaracetam tablets, in India, for treatment of epilepsy

March 1, 2021

Press Release Feb 26 2021

February 26, 2021

NATCO Pharma receives approval for Chlorantraniliprole 1st key product of Crop Health Sciences Division

February 8, 2021

Press Release Feb 05 2021

February 5, 2021

Decks in 2021